Jennifer Villasenor-Park
Dermatology
3400 Civic Center Boulevard
South Pavilion, 1st Floor
Philadelphia, PA 19104
South Pavilion, 1st Floor
Philadelphia, PA 19104
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Safety of Concurrent Systemic Therapy and Total Skin Electron Therapy in Cutaneous T-Cell Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 09, 2026
Standard Versus Hypofractionated Low-Dose Total Skin Electron Therapy for Cutaneous T-Cell Lymphoma: A Single-Institution Retrospective Analysis.
Journal: Practical radiation oncology
Published: December 16, 2025
Cutaneous B-Cell Lymphomas.
Journal: Hematology/oncology clinics of North America
Published: July 24, 2024
Retrospective cohort study of novel oral agents lenalidomide and duvelisib for relapsed or refractory mycosis fungoides and Sézary syndrome.
Journal: Journal of the American Academy of Dermatology
Published: July 21, 2024
Recent trends in skin directed and self-administered systemic treatment costs in the United States for Cutaneous T-cell Lymphoma.
Journal: Journal of the American Academy of Dermatology
Published: March 04, 2022
Usage and safety of topical tacrolimus in patients with mycosis fungoides.
Journal: Clinical and experimental dermatology
Published: February 25, 2022
A healthy 16-year-old boy presenting with multifocal asymptomatic subcutaneous nodules.
Journal: Pediatric dermatology
Published: February 02, 2022
Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome.
Journal: JAMA dermatology
Published: December 30, 2020
Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular Analysis.
Journal: JAMA dermatology
Published: October 28, 2020
Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome.
Journal: Current hematologic malignancy reports
Published: May 26, 2017
Last Updated: 09/26/2026